Amanote Research
Register
Sign In
Use of Octreotide Acetate to Prevent Rebound Hypoglycaemia in Sulfonylurea Overdose
Emergency Medicine Journal
- United Kingdom
doi 10.1136/emj.2007.051326
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Critical Care
Emergency Medicine
Intensive Care Medicine
Date
August 1, 2007
Authors
Z. Hassan
J. Wright
Publisher
BMJ
Related search
Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
How to Use a Controlled Fast to Investigate Hypoglycaemia
Archives of Disease in Childhood: Education and Practice Edition
Child Health
Pediatrics
Perinatology
Effect of Octreotide Acetate on Hypoxemia in a Patient With Liver Cirrhosis.
Acta Hepatologica Japonica
Hepatology
How to Prevent Viremia Rebound? Evidence From a PRRSv Data-Supported Model of Immune Response
BMC Systems Biology
Molecular Biology
Applied Mathematics
Structural Biology
Simulation
Computer Science Applications
Modeling
Community-Based Interventions to Prevent Fatal Overdose From Illegal Drugs: A Systematic Review Protocol: Table 1
BMJ Open
Medicine
Local Health Department Partnerships to Address Opioid Use and Overdose Prevention
Journal of public health management and practice : JPHMP
Health Policy
Public Health
Occupational Health
Environmental
Use of Lucozade and Glucagon by Ambulance Staff in Hypoglycaemia.
BMJ
The Use of Somatostatin and Octreotide in the Treatment of Gastrointestinal Bleeding
Medicinski Casopis
Medicine
Inadequate Use of Immunization to Prevent Severe Pneumococcal Infection
Clinical Infectious Diseases
Infectious Diseases
Microbiology